Rick E. Winningham - May 20, 2025 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol: TBPH
Transactions as of: May 20, 2025
Transactions value $: -$145,190
Form type: 4
Date filed: 5/22/2025, 06:44 PM
Previous filing: Mar 4, 2025
Next filing: Jun 17, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Winningham Rick E	CHIEF EXECUTIVE OFFICER, Director	C/O THERAVANCE BIOPHARMA US, LLC, 901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO	/s/ Brett A. Grimaud, Attorney-in-Fact	2025-05-22	0001302443

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TBPH	Ordinary Shares	Tax liability	-$145K	-15.4K	-0.86%	$9.45	1.76M	May 20, 2025	Direct	F1
holding	TBPH	Ordinary Shares						3.9K	May 20, 2025	As Custodian
holding	TBPH	Ordinary Shares						92.6K	May 20, 2025	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.